Kandarp Maheshkumar Dave

Title: Kandarp Maheshkumar Dave: Innovator in Parenteral Dosage Forms

Introduction

Kandarp Maheshkumar Dave is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of parenteral dosage forms. With a total of three patents to his name, his work has the potential to enhance the stability and efficacy of critical medications.

Latest Patents

One of his latest patents is a parenteral dosage form of diltiazem. This invention relates to a ready-to-infuse, stable aqueous solution that comprises diltiazem or its pharmaceutically acceptable salt, a pH adjusting agent to provide a pH in the range of 3 to 5, and ethanol. Another significant patent is for a parenteral dosage form of norepinephrine. This invention features a ready-to-administer aqueous solution of norepinephrine, which includes an anti-oxidant that is not a sulfite anti-oxidant, ensuring the dosage form remains stable at room temperature for an extended period.

Career Highlights

Kandarp has worked with prominent companies in the pharmaceutical industry, including Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Samarth Kumar and Milan Natvarbhai Thakkar. Their collaboration has likely fostered a creative environment that encourages innovation in pharmaceutical research.

Conclusion

Kandarp Maheshkumar Dave is a distinguished inventor whose work in parenteral dosage forms has the potential to significantly impact the pharmaceutical industry. His patents reflect a commitment to improving medication stability and efficacy, showcasing his valuable contributions to healthcare.